Henderson Clinical Trials

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• High blood pressure2 trials
• Obstructive sleep apnoea2 trials
• Psoriasis2 trials
• Chronic kidney disease1 trial
• COPD1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Obesity1 trial
• Peripheral artery disease1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials
• Phase 22 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting4 trials
• Completed3 trials
• Recruiting2 trials
• Enrolling by invitation1 trial

Lead sponsor

• Apnimed2 trials
• Mineralys Therapeutics Inc.2 trials
• Pfizer2 trials
• Takeda2 trials
• Eli Lilly and Company1 trial
• and 1 more

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  NCT07363694· Phase 2/3· Pfizer· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  NCT06977581· Phase 2· Pfizer· Source

• Active, not recruiting

  A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

  NCT06550076· Phase 3· Takeda· Source

• Active, not recruiting

  Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

  NCT06572228· Phase 4· Regeneron Pharmaceuticals· Source

• Enrolling by invitation

  Continuation Protocol for Obstructive Sleep Apnea (OSA)

  NCT06566820· Phase 3· Apnimed· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension

  NCT05968430· Phase 3· Mineralys Therapeutics Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting
• COPD1 recruiting
• Obstructive sleep apnoea1 recruiting

Closed trials

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

  NCT06088043· Phase 3· Takeda· Source

• Completed

  Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

  NCT05811247· Phase 3· Apnimed· Source

• Completed

  A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

  NCT05769608· Phase 2· Mineralys Therapeutics Inc.· Source